Abatacept Biosimilar – Anti-CTLA-4 extracellular domain linked to IgG1 Fc mAb – Research Grade

Reference:
Size

,

Brand

Product type

Clonality

Expression system

Description of Abatacept Biosimilar - Anti-CTLA-4 extracellular domain linked to IgG1 Fc mAb - Research Grade

General information about Abatacept

Abatacept est une protéine de fusion composée du domaine extracellulaire de l’antigène 4 cytotoxique humain associé au lymphocyte T (CTLA-4) lié à une partie Fc modifiée d’immunoglobuline humaine (IgG1) qui inhibe le signal de co-stimulation CD80/86 nécessaire à l’activation des lymphocytes T exprimant le CD28. This product is for research use only.

Product nameAbatacept Biosimilar - Anti-CTLA-4 extracellular domain linked to IgG1 Fc mAb - Research Grade
SourceDrugBank DB01281
SpeciesHuman
Expression systemMammalian cells
Molecular weight92kDa
Purity>90%
BufferPBS pH7.5
Delivery conditionDry Ice
Delivery Time3-5 days if in stock; 3-5 weeks if production needed
Storage condition4°C for short term; -20°C for long term
BrandProteoGenix
Aliases /SynonymsAbatacept
ReferencePX-TA1020
Related ProductsCTLA-4 Protein/ Cytotoxic T-lymphocyte protein 4 recombinant protein
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypehG1-Fc
ClonalityMonoclonal Antibody
SourceDrugBank DB01281

Reviews

There are no reviews yet.

Be the first to review “Abatacept Biosimilar – Anti-CTLA-4 extracellular domain linked to IgG1 Fc mAb – Research Grade”

Your email address will not be published. Required fields are marked *


Clear
OK

Please select the country of delivery so that we can send you the quotation including shipping costs.

Thank you for your request! You will receive your quotation per e-mail in a few seconds.

If you did not receive your quotation, please check your spam folder.

Contact us to order

+33 (0)3 90 20 54 70

Write us

Categories: